Drug Trial Radar · NCT03706261
Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults
Last checked: Nov 20, 2026Latest source record: Aug 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
145
Actual
Start
Mar 22, 2019
Primary completion
Jul 14, 2023
Study completion Jul 14, 2023
Sponsor
- Lead sponsor
- Adam BrickmanAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- First posted
- Oct 15, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 35 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study employs tau positron emission tomography (PET) imaging in a well-characterized multi-racial/ethnic cohort to examine the extent to which tau pathology is associated with cognition, differences in tau pathology across racial/ethnic groups, and the relationship between MRI markers of small-vessel cerebrovascular disease and tau pathology. The study also investigates amyloid-dependent tau spreading.
Conditions
- Alzheimer Disease
Interventions
18F-MK-6240Drug
Administration of 5 mCi of 18F-MK-6240 for tau PET.
18F-FlorbetabenDrug
Administration of 8.1 mCi as a slow single intravenous bolus (6 sec/mL) in a total volume of up to 10 mL of 18F-Florbetaben for Aβ PET imaging.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Regional SUVR Value for 18F-MK-6240Time frame: 1 day
- Number of Participants With Amyloid Positivity (Aβ+) for 18F-FlorbetabenTime frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Columbia University Irving Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.